Related Experiment Video

Updated: Jul 2, 2026

Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

Negative regulation of lymphocyte development and function by the Cbl family of proteins

Fang Huang1, Hua Gu

  • 1Fudan Medical School, Fudan University, Shanghai, China.

Immunological Reviews
|September 2, 2008
PubMed

Insights

The Cbl family of proteins (c-Cbl and Cbl-b) are crucial negative regulators of immune cell signaling. Their inactivation enhances anti-tumor immunity, suggesting therapeutic potential for cancer and autoimmunity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Antigen receptors and coreceptors regulate lymphocyte development and activation through intracellular signaling.
  • The Cbl family of ubiquitin ligases (c-Cbl and Cbl-b) are identified as key negative regulators in T-cell and B-cell signaling.

Purpose of the Study:

  • To investigate the role of c-Cbl and Cbl-b in lymphocyte development, activation, and immune regulation.
  • To explore the therapeutic potential of modulating Cbl protein signaling in autoimmunity and cancer.

Main Methods:

  • Studied the function of c-Cbl and Cbl-b in T-cell and B-cell development and activation.
  • Utilized biochemical studies to correlate immune regulation with ubiquitin ligase function.
  • Examined the impact of Cbl-b inactivation on anti-tumor immunity in mice.

Main Results:

  • c-Cbl and Cbl-b exhibit redundant roles in thymocyte development and thymic selection.
  • These proteins control T-cell activation thresholds and CD28 costimulatory signaling.
  • In B cells, c-Cbl and Cbl-b regulate B-cell receptor signaling, maturation, and anergy induction.
  • Inactivation of Cbl-b enhances CD8(+) T cell-mediated anti-tumor immunity, conferring resistance to tumors.

Conclusions:

  • Cbl proteins are central regulators of a complex immune network.
  • Modulating Cbl protein signaling pathways may offer therapeutic benefits for autoimmune diseases and cancer treatment.

More Related Videos

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...